Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis

Neurology

Volumn 75, Issue 14, 2010, Pages 1234-1240

  Calabrese, M ^a   Battaglini, M ^b   Giorgio, A ^b   Atzori, M ^a   Bernardi, V ^a   Mattisi, I ^a   Gallo, P ^a   De Stefano, N ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN CORTEX; BRAIN CORTEX LESION; CINGULATE GYRUS; FEMALE; FRONTAL LOBE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TEMPORAL LOBE; ADOLESCENT; AGED; BRAIN MAPPING; DISABILITY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; STATISTICS;

ADOLESCENT; ADULT; AGED; BRAIN MAPPING; CEREBRAL CORTEX; DISABILITY EVALUATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 77958194104     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181f5d4da     Document Type: Article

References (37)

1. Geurts JJ, Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol 2008;7:841-851.
2. Bo L. The histopathology of grey matter demyelination in multiple sclerosis. Acta Neurol Scand Suppl 2009;189:51-57.
3. Stadelmann C, Albert M, Wegner C, Bruck W. Cortical pathology in multiple sclerosis. Curr Opin Neurol 2008; 21:229-234.
4. Filippi M, Valsasina P, Rocca M. Magnetic resonance imaging of grey matter damage in people with MS. Int MS J 2007;14:12-21.
5. Chard D, Miller D. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging. J Neurol Sci 2009;282:5-11.
6. Geurts JJ, Pouwels PJ, Uitdehaag BM, Polman CH, Bark-hof F, Castelijns JA. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 2005;236:254-260.
7. Calabrese M, De Stefano N, Atzori M, et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol 2007;64:1416-1422.
8. Bagnato F, Butman JA, Gupta S, et al. In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis. AJNR Am J Neuroradiol 2006;27:2161-2167. (Pubitemid 44788650)
9. Nelson F, Poonawalla AH, Hou P, Huang F, Wolinsky JS, Narayana PA. Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am J Neuroradiol 2007;28:1645-1649.
10. Mainero C, Benner T, Radding A, et al. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology 2009;73:941-948.
11. Calabrese M, Rocca MA, Atzori M, et al. Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology 2009;72:1330-1336.
12. Calabrese M, Agosta F, Rinaldi F, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009; 66:1144-1150.
13. Roosendaal SD, Moraal B, Pouwels PJ, et al. Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult Scler 2009;15:708-714.
14. Calabrese M, De Stefano N, Atzori M, et al. Extensive cortical inflammation is associated with epilepsy in multiple sclerosis. J Neurol 2008;255:581-586.
15. Calabrese M, Filippi M, Rovaris M, et al. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. Mult Scler 2009;15:36-41.
16. Calabrese M, Mattisi I, Favaretto A, et al. Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis. J Neurol Neurosurg Psychiatry 2010;81:401-404.
17. Narayanan S, Fu L, Pioro E, et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997;41:385-391.
18. Lee MA, Smith S, Palace J, et al. Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis? Brain 1999;122:1261-1270.
19. Charil A, Zijdenbos AP, Taylor J, et al. Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage 2003;19:532-544.
20. Di Perri C, Battaglini M, Stromillo ML, et al. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. Arch Neurol 2008;65:236-243.
21. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127.
22. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005;58:840-846.
23. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey: National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-911.
24. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
25. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143-155.
26. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuni-formity in MRI data. IEEE Trans Med Imaging 1998; 17:87-97.
27. Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143-156.
28. Andersson JLR, Jenkinson M, Smith S. Non-linear registration, aka Spatial normalization: FMRIB technical report TR07JA2; 2007. Available at: www.fmrib.ox.ac.uk/analysis/techrep. Accessed August 18, 2010.
29. Lumsden CE. The neuropathology of multiple sclerosis. Amsterdam: North-Holland; 1970.
30. Bo L, Vedeler CA, Nyland HI, Trapp BD, Mork SJ. Sub-pial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003;62:723-732.
31. Vercellino M, Plano F, Votta B, Mutani R, Giordana MT, Cavalla P. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005;64:1101-1107.
32. Pomeroy I, Jordan E, Frank J, Matthews P, Esiri M. Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis. Mult Scler 2010;16:537-548.
33. Buckner RL, Snyder AZ, Shannon BJ, et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 2005;25:7709-7717.
34. Calabrese M, Filippi M, Rovaris M, et al. Morphology and evolution of cortical lesions in multiple sclerosis: a longitudinal MRI study. Neuroimage 2008;42:1324-1328.
35. Thompson AJ, Kermode AG, Wicks D, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991;29:53-62.
36. Nijeholt GJ, van Walderveen MA, Castelijns JA, et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 1998;121:687-697.
37. Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 2002;15:1-25.